Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Grapes in Diet Decrease Risk of Hypertensive Heart Failure
New results presented at the Second International Symposium on Human Health Effects of Fruits and Vegetables in Houston, Texas last week showed that a grape-enriched diet improved cardiac function, prevented enlargement of the heart and kidneys, and reduced cardiac and renal oxidative damage in rats prone to heart failure.
- Grapes in Diet Decrease Risk of Hypertensive Heart Failure
New results presented at the Second International Symposium on Human Health Effects of Fruits and Vegetables in Houston, Texas last week showed that a grape-enriched diet improved cardiac function, prevented enlargement of the heart and kidneys, and reduced cardiac and renal oxidative damage in rats prone to heart failure.
- SourceOne’s Sytrinol® Supports Healthy Cholesterol Naturally in Multiple Studies
SourceOne™ Global Partners has announced that the peer-reviewed journal, Alternative Therapies in Health and Medicine, has published the results of a study involving 120 subjects that demonstrated the heart healthy benefits of Sytrinol®, a patented proprietary formula derived from PMFsource™ Citrus Bioflavonoids and TocoSource™ Palm Tocotrienols.
- SourceOne’s Sytrinol® Supports Healthy Cholesterol Naturally in Multiple Studies
SourceOne™ Global Partners has announced that the peer-reviewed journal, Alternative Therapies in Health and Medicine, has published the results of a study involving 120 subjects that demonstrated the heart healthy benefits of Sytrinol®, a patented proprietary formula derived from PMFsource™ Citrus Bioflavonoids and TocoSource™ Palm Tocotrienols.
- SourceOne’s Sytrinol® Supports Healthy Cholesterol Naturally in Multiple Studies
SourceOne™ Global Partners has announced that the peer-reviewed journal, Alternative Therapies in Health and Medicine, has published the results of a study involving 120 subjects that demonstrated the heart healthy benefits of Sytrinol®, a patented proprietary formula derived from PMFsource™ Citrus Bioflavonoids and TocoSource™ Palm Tocotrienols.
- Co-Q10 Studies Validate the Benefits of Q-absorb(TM)
In one study, Italian scientists from the Lancisi Heart Institute and the University of Ancona (Institute of Biochemistry) measured the effects of 300 mg per day (100 mg T.I.D.) Q-absorb(TM) on the cardiovascular functional capacity of 23 heart patients, observing that the product improved functional capacity and endothelial-dependent vasodilation, and tripled plasma coenzyme Q 10 levels. In the other study, CoQ10 administration increased levels of Superoxide Dismutase (SOD) in the patient population.
- Co-Q10 Studies Validate the Benefits of Q-absorb(TM)
In one study, Italian scientists from the Lancisi Heart Institute and the University of Ancona (Institute of Biochemistry) measured the effects of 300 mg per day (100 mg T.I.D.) Q-absorb(TM) on the cardiovascular functional capacity of 23 heart patients, observing that the product improved functional capacity and endothelial-dependent vasodilation, and tripled plasma coenzyme Q 10 levels. In the other study, CoQ10 administration increased levels of Superoxide Dismutase (SOD) in the patient population.
- Co-Q10 Studies Validate the Benefits of Q-absorb(TM)
In one study, Italian scientists from the Lancisi Heart Institute and the University of Ancona (Institute of Biochemistry) measured the effects of 300 mg per day (100 mg T.I.D.) Q-absorb(TM) on the cardiovascular functional capacity of 23 heart patients, observing that the product improved functional capacity and endothelial-dependent vasodilation, and tripled plasma coenzyme Q 10 levels. In the other study, CoQ10 administration increased levels of Superoxide Dismutase (SOD) in the patient population.
- Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
Company announces results of a clinical trial known as the ICARE study, being presented today at the American Heart Association's (AHA) Scientific Sessions 2007 demonstrating that supplementing Vitamin E therapy in patients with Diabetes Mellitus (DM) who had the Haptoglobin 2-2 (Hp2-2) phenotype met its pre-specified, primary endpoint of decreased cardiovascular events.
- Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
Company announces results of a clinical trial known as the ICARE study, being presented today at the American Heart Association's (AHA) Scientific Sessions 2007 demonstrating that supplementing Vitamin E therapy in patients with Diabetes Mellitus (DM) who had the Haptoglobin 2-2 (Hp2-2) phenotype met its pre-specified, primary endpoint of decreased cardiovascular events.
- Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
Company announces results of a clinical trial known as the ICARE study, being presented today at the American Heart Association's (AHA) Scientific Sessions 2007 demonstrating that supplementing Vitamin E therapy in patients with Diabetes Mellitus (DM) who had the Haptoglobin 2-2 (Hp2-2) phenotype met its pre-specified, primary endpoint of decreased cardiovascular events.
- Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
Company announces results of a clinical trial known as the ICARE study, being presented today at the American Heart Association's (AHA) Scientific Sessions 2007 demonstrating that supplementing Vitamin E therapy in patients with Diabetes Mellitus (DM) who had the Haptoglobin 2-2 (Hp2-2) phenotype met its pre-specified, primary endpoint of decreased cardiovascular events.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Vitamin E Could Help 40% of Diabetics Ward off Heart Attacks According to the Technion-Israel Institute of Technology
According to researchers at the Technion-Israel Institute of Technology and the Clalit Health Services in Israel, citing a study published in the November 21 online edition of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, people with the haptoglobin (Hp) 2-2 gene who took 400 International Units (IU) of vitamin E daily had more than 50 percent fewer heart attacks, strokes, and related deaths than Hp 2-2 patients who took a placebo pill. 40% of individuals with diabetes carry the Hp 2-2 gene.
- Calcium Supplementation and Heart Attack Risk? Vitamin K2 May Be A Solution
PL Thomas and researchers from Maastricht University, the Netherlands hae commented on recent research linking calcium supplementation to increased risk of heart attack, reported in the British Medical Journal’s January 16th issue: “There are two vitamins known to be involved in calcium metabolism: vitamin D and vitamin K. Increased calcium intake, especially if combined with vitamin D, results in increased absorption of calcium......"
- Calcium Supplementation and Heart Attack Risk? Vitamin K2 May Be A Solution
PL Thomas and researchers from Maastricht University, the Netherlands hae commented on recent research linking calcium supplementation to increased risk of heart attack, reported in the British Medical Journal’s January 16th issue: “There are two vitamins known to be involved in calcium metabolism: vitamin D and vitamin K. Increased calcium intake, especially if combined with vitamin D, results in increased absorption of calcium......"
- Calcium Supplementation and Heart Attack Risk? Vitamin K2 May Be A Solution
PL Thomas and researchers from Maastricht University, the Netherlands hae commented on recent research linking calcium supplementation to increased risk of heart attack, reported in the British Medical Journal’s January 16th issue: “There are two vitamins known to be involved in calcium metabolism: vitamin D and vitamin K. Increased calcium intake, especially if combined with vitamin D, results in increased absorption of calcium......"
- New Cochrane Study Supports Bioforce AG Original Research On Efficacy of Crataegus (Hawthorn)
A recent Cochrane Review study that found hawthorn extract may benefit in treatment of chronic heart failure validates an earlier study by Bioforce AG researchers.
- New Cochrane Study Supports Bioforce AG Original Research On Efficacy of Crataegus (Hawthorn)
A recent Cochrane Review study that found hawthorn extract may benefit in treatment of chronic heart failure validates an earlier study by Bioforce AG researchers.
- New Cochrane Study Supports Bioforce AG Original Research On Efficacy of Crataegus (Hawthorn)
A recent Cochrane Review study that found hawthorn extract may benefit in treatment of chronic heart failure validates an earlier study by Bioforce AG researchers.
- Study Indicates That Sensoril(R) Found To Significantly Reduce Stress Parameters and Cardiovascular Risk in Humans
According to a human clinical study just published in the Journal of the American Nutraceutical Association (JANA), the Withania somnifera extract (WSE) in Sensoril(R) significantly reduced stress-related parameters and cardiovascular risk.
- Study Indicates That Sensoril(R) Found To Significantly Reduce Stress Parameters and Cardiovascular Risk in Humans
According to a human clinical study just published in the Journal of the American Nutraceutical Association (JANA), the Withania somnifera extract (WSE) in Sensoril(R) significantly reduced stress-related parameters and cardiovascular risk.
- Study Indicates That Sensoril(R) Found To Significantly Reduce Stress Parameters and Cardiovascular Risk in Humans
According to a human clinical study just published in the Journal of the American Nutraceutical Association (JANA), the Withania somnifera extract (WSE) in Sensoril(R) significantly reduced stress-related parameters and cardiovascular risk.
- Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
New research in pigs published in the British Journal of Nutrition (Br J Nutr., Dec. 17, PMID: 18081945, 2007) shows that blueberries may have a cardio-protective effect, by significantly lowering cholesterol.
- Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
New research in pigs published in the British Journal of Nutrition (Br J Nutr., Dec. 17, PMID: 18081945, 2007) shows that blueberries may have a cardio-protective effect, by significantly lowering cholesterol.
- Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
New research in pigs published in the British Journal of Nutrition (Br J Nutr., Dec. 17, PMID: 18081945, 2007) shows that blueberries may have a cardio-protective effect, by significantly lowering cholesterol.
- Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
New research in pigs published in the British Journal of Nutrition (Br J Nutr., Dec. 17, PMID: 18081945, 2007) shows that blueberries may have a cardio-protective effect, by significantly lowering cholesterol.
- Published Study Suggests Next Pharmaceuticals' Flavoxine(TM) Reduces Multiple Heart Health Risk Factors
Next Pharmaceuticals has announced the results of a placebo-controlled, randomized, double-blind clinical trial, published in Nutrition Journal, indicating that the company's Flavoxine significantly reduced LDL-cholesterol and triglycerides, while it significantly decreased blood pressure and fasting blood glucose.
- Published Study Suggests Next Pharmaceuticals' Flavoxine(TM) Reduces Multiple Heart Health Risk Factors
Next Pharmaceuticals has announced the results of a placebo-controlled, randomized, double-blind clinical trial, published in Nutrition Journal, indicating that the company's Flavoxine significantly reduced LDL-cholesterol and triglycerides, while it significantly decreased blood pressure and fasting blood glucose.
- Published Study Suggests Next Pharmaceuticals' Flavoxine(TM) Reduces Multiple Heart Health Risk Factors
Next Pharmaceuticals has announced the results of a placebo-controlled, randomized, double-blind clinical trial, published in Nutrition Journal, indicating that the company's Flavoxine significantly reduced LDL-cholesterol and triglycerides, while it significantly decreased blood pressure and fasting blood glucose.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Arterial Calcification Reduced With Vitamin K2 Intake According to New Study
PL Thomas and NattoPharma have announced that a new study demonstrated the association of high dietary Vitamin K2 consumption with reduction of coronary calcification in humans.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Cognis Puts Spotlight on Heart Health at SupplySide West
- Cognis Puts Spotlight on Heart Health at SupplySide West
- Cognis Puts Spotlight on Heart Health at SupplySide West
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Aug 1st, 2008 – Edison, NJ – Carotech Inc, the only GMP-certified tocotrienol producer is pleased to announce a new study that proves that gamma-tocotrienol is the most potent form of tocotrienol for cardiovascular protection.
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats.
The results showed that all forms of tocotrienols used (the palm tocotrienol complex and individual tocotrienol isomers) were able to provide significant cardioprotection. However, gamma-tocotrienol was the most cardioprotective of all the isomers. This is an interesting finding with far reaching consequence as the gamma-tocotrienol form (including gamma-tocopherol) is the most abundantly found in our diet.
Gamma-tocotrienol was the most effective in :-
1. Improving post-ischemic ventricular function
2. Reducing myocardial infarct size
3. Reducing the percentage of apoptotic cardiomyocytes
4. Partially protecting the proteasome during ischemia
5. Producing the least MDA content in heart
6. Significantly enhancing Akt Phosphorylation (improve survival).
Alpha-tocotrienol was the second most protective in improving the effects shown above. Interestingly, delta-tocotrienol was the least potent. Except from being able to inhibit deactivation of proteasomes, delta-tocotrienol did not show significant cardioprotection. The results indicate, that contrary to popular belief, delta-tocotrienol is not the most cardioprotective form of tocotrienol.
The cardioprotection conferred by tocotrienols does not appear to be potentiated by their antioxidant abilities, but likely to be caused by the different effects individual tocotrienol isomers have on the c-Src inhibition and/or proteasome protection. An earlier study has demonstrated the relationship of proteasome in tocotrienol-mediated cardioprotection. The researcher suggested that during ischemia, the partial deactivation of proteasome by tocotrienols especially the gamma-tocotrienol and alpha-tocotrienol isomers results in effective removal of active Src (which generates pro-death signal) and at the same time, increases the Akt phosphorylation (which generates pro-survival signal). This creates a balance between cell survival and cell death signals. Delta-tocotrienol on the other hand, completely inhibited the proteasome dysfunction, resulting in the least Akt phosphorylation and thus low survival signals.
The researchers also concluded that tocotrienols have much higher cardioprotective properties compared to regular alpha-tocopherol vitamin E.
“This study has proven that gamma-tocotrienol and alpha-tocotrienol have the highest cardioprotective function but not delta-tocotrienol. Similar to what is found in nature (palm oil, rice bran oil, wheat, etc) Carotech’s Tocomin® has the highest levels of gamma- and alpha-tocotrienol, making it the preferred choice of mixed tocotrienols for nutritional supplements for heart health,” explained WH Leong, Vice President of Carotech Inc
About Carotech Ltd
Carotech Berhad, incorporated in 1992, is a public listed company in Malaysia (MESDAQ Board). It is the first and largest producer of natural full spectrum tocotrienol complex (Tocomin® & Tocomin® SupraBio™,), natural mixed carotene complex (Caromin®) and phytosterol complex (StelessterolTM) in the world via its patented technology.
Carotech is the only GMP-Certified tocotrienol producer in the world.
Carotech is a subsidiary of Hovid Berhad (www.hovid.com), one of the largest GMP-certified pharmaceutical companies in Malaysia.
Carotech manufactures these products under the tradenames : Tocomin®, Tocomin®SupraBio™, Caromin® and Stelessterol™.
Websites : www.carotech.net and www.tocotrienol.org
Contact:
WH Leong
Vice President
Carotech Inc
732 906 1901
info@carotech.net |